Palliative care for women undergoing chemotherapy for ovarian cancer versus standard oncologic care: an analysis of outcomes

Background: A significant number of deaths and injuries are associated with the frequently late diagnosis of ovarian cancer.Psychological care is an essential component of palliative care.Effective palliative care for women undergoing chemotherapy for ovarian cancer recognizes the psychological impact of a serious illness and integrates psychological support to help these patients and their families cope.Aim: This research aims to evaluate how post-palliative care and standard oncologic care compare in terms of enhancing psychological support, overall wellbeing, pain relief, and quality of life in women undergoing chemotherapy for ovarian cancer.Methods: Participants will be randomly assigned to receive post-palliative care (Group B: n=75) and standard oncologic care (Group A: n=75).The outcomes will include patient satisfaction, healthcare utilization, psychological well-being, the impact of psychological support, pain relief, and quality of life offered through postilliative care.Data will be collected at baseline and follow-up intervals of three, six, and twelve months.SPSS 26 version software has been employed for statistical analysis and will involve mixed-effects models to assess longitudinal changes, alongside independent t-tests, chi-square tests, and ANOVA for baseline comparisons.Results: Participants reported high symptom burden and poor quality of life at baseline.It is predicted that Group B will demonstrate significantly lower symptom burden, improved quality of life, enhanced psychological support, and higher patient satisfaction and psychological well-being compared to Group A. The results suggest that post-palliative care could lead to enhanced Patient Satisfaction-90%, Healthcare Utilization-20%, Psychological Well-Being-85%, Impact of Psychological Support-80%, Pain Relief-85%, and Quality of Life-80%.Conclusion: Integrating palliative care, particularly its psychological support components, into standard oncologic care for women undergoing chemotherapy for ovarian cancer could significantly enhance patient outcomes and overall well-being, warranting its routine consideration.